Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Letters to the Editor
You have accessRestricted Access

Fibroblast Growth Factor-23 May Follow Cardiovascular Disease Rather than Causing It in Chronic Kidney Disease

Chenchen Zhou, Changlin Mei, Bing Dai and Cheng Xue
JASN October 2018, 29 (10) 2602; DOI: https://doi.org/10.1681/ASN.2018050517
Chenchen Zhou
1Department of Nephrology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China; and
2Division of Nephrology, Changzheng Hospital, Second Military Medical University, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Changlin Mei
2Division of Nephrology, Changzheng Hospital, Second Military Medical University, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bing Dai
2Division of Nephrology, Changzheng Hospital, Second Military Medical University, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheng Xue
2Division of Nephrology, Changzheng Hospital, Second Military Medical University, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • View PDF
Loading

Article Information

vol. 29 no. 10 2602
DOI 
https://doi.org/10.1681/ASN.2018050517
PubMed 
30093457

Published By 
American Society of Nephrology
Print ISSN 
1046-6673
Online ISSN 
1533-3450
History 
  • Published online September 28, 2018.

Article Versions

  • Earlier version (August 9, 2018 - 09:22).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2018 by the American Society of Nephrology

Author Information

  1. Chenchen Zhou1,2,
  2. Changlin Mei2,
  3. Bing Dai2 and
  4. Cheng Xue2
  1. 1Department of Nephrology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China; and
  2. 2Division of Nephrology, Changzheng Hospital, Second Military Medical University, Shanghai, China
  1. Correspondence:
    Dr. Cheng Xue, Division of Nephrology, Changzheng Hospital, Second Military Medical University, Fengyang Road 415, Shanghai 200000, China. Email: xuecheng{at}smmu.edu.cn

Statistics from Altmetric.com

Article usage

Article usage: August 2018 to December 2020

AbstractFullPdf
Aug 2018013664
Sep 2018014125
Oct 2018026854
Nov 2018015028
Dec 20180624
Jan 201906610
Feb 20190264
Mar 201904310
Apr 20190333
May 201902416
Jun 201902310
Jul 20190219
Aug 201902913
Sep 201905913
Oct 20190146
Nov 201902222
Dec 20190176
Jan 2020094
Feb 202002116
Mar 202001610
Apr 20200156
May 20200127
Jun 20200146
Jul 20200117
Aug 20200118
Sep 20200206
Oct 20200148
Nov 202002013
Dec 20200196

Cited By...

  • 3 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 29 (10)
Journal of the American Society of Nephrology
Vol. 29, Issue 10
October 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Fibroblast Growth Factor-23 May Follow Cardiovascular Disease Rather than Causing It in Chronic Kidney Disease
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Fibroblast Growth Factor-23 May Follow Cardiovascular Disease Rather than Causing It in Chronic Kidney Disease
Chenchen Zhou, Changlin Mei, Bing Dai, Cheng Xue
JASN Oct 2018, 29 (10) 2602; DOI: 10.1681/ASN.2018050517

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Fibroblast Growth Factor-23 May Follow Cardiovascular Disease Rather than Causing It in Chronic Kidney Disease
Chenchen Zhou, Changlin Mei, Bing Dai, Cheng Xue
JASN Oct 2018, 29 (10) 2602; DOI: 10.1681/ASN.2018050517
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Authors’ Reply
  • Remdesivir in COVID-19 Patients with Impaired Renal Function
  • Post-Mortem Diagnostics in COVID-19 AKI, More Often but Timely
Show more Letters to the Editor

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • Fibroblast Growth Factor-23 Is Not a Single Bystander in Chronic Kidney Disease Mortality
  • Authors’ Reply
  • PubMed
  • Google Scholar

Keywords

  • cardiovascular disease
  • fibroblast
  • chronic kidney disease

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire